PedsEndoPhilly said:sarah.morrison said: ...my insurance denied cost and coverage coverage because...
PedsEndoPhilly said:...compounded vs brand cost and coverage...
This debate comes up weekly and I think both sides have valid points:
Pro-brand: FDA-approved, manufacturing standards guaranteed, clinical trial data directly applicable
Pro-compounded: 10x cost savings, same active molecule, independent testing available, accessibility
My position: if you can afford brand or have insurance coverage, that's the gold standard. If not, properly tested compounded from a 503B pharmacy is a reasonable alternative. Neither side should shame the other.
Dr.DermMIA said:Telehealth prescriber review for cost and coverage: I've used 3 different telehealth platforms to get my GLP-1 prescription.
Thank you — that is the clearest version of this I have read, and I have read a lot of them.
PedsEndoPhilly said:sarah.morrison said: ...my insurance denied cost and coverage coverage because...
Financial impact of cost and coverage weight loss beyond medication cost:
- Groceries: SAVED $290/month (eating less)
- Restaurants: SAVED $180/month (fewer meals out)
- Alcohol: SAVED $130/month (stopped drinking)
- Life insurance: Premium REDUCED by $40/month (lower BMI)
- Copays: SAVED $60/month (fewer BP/cholesterol meds)
Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsTomFromTexas said:Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…
TomFromTexas said:...regarding the discontinuation data for cost and coverage...
I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."
Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.
This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.
Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Carry on.